home / stock / clbtw / clbtw news


CLBTW News and Press, Cellebrite DI Ltd. Warrants From 03/21/24

Stock Information

Company Name: Cellebrite DI Ltd. Warrants
Stock Symbol: CLBTW
Market: NASDAQ
Website: cellebrite.com

Menu

CLBTW CLBTW Quote CLBTW Short CLBTW News CLBTW Articles CLBTW Message Board
Get CLBTW Alerts

News, Short Squeeze, Breakout and More Instantly...

CLBTW - Cellebrite Files its 2023 Annual Report on Form 20-F

TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 21, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (Nasdaq: CLBT), a leader in premier Digital Investigative solutions for the public and private sectors, today announced that the Company has filed its Annual Report on Form 20-F for the year ended De...

CLBTW - Cellebrite Revolutionizes Data Collection with Ground-breaking SaaS Solution, Integral Part of Company's Case-to-Closure Platform

TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 14, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (Nasdaq: CLBT), a leader in Digital Investigative solutions, today unveils Cellebrite Endpoint Inspector SaaS. This enhanced delivery model of our industry-leading Endpoint Inspector product offers e...

CLBTW - UPDATE - Cellebrite Announces 2024 Investor Day

TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 12, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced that it is hosting an Investor Day in New York City on Wednesday, March 27, 2024...

CLBTW - Cellebrite Announces 2024 Investor Day

TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 12, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced that it is hosting an Investor Day in New York City on Wednesday, March 27, 2024...

CLBTW - Cellebrite Launches FedRAMP Authorization Process to Provide Federal Customers with Enhanced Cloud Security

TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 07, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd . (Nasdaq: CLBT), a global leader in Digital Investigative solutions for the public and private sectors, today announced the launch of the process to authorize its software-as-a-service offerings ...

CLBTW - Haim Shani Concludes Tenure at Cellebrite as Company Enters Next Growth Phase

TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 06, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (Nasdaq: CLBT), a leader in premier Digital Investigative solutions for the public and private sectors, today announced that Haim Shani has retired as a director of the Company, effective immediately...

CLBTW - Cellebrite DI Ltd. (CLBT) Q4 2023 Earnings Call Transcript

2024-02-15 12:01:03 ET Cellebrite DI Ltd. (CLBT) Q4 2023 Earnings Conference Call February 15, 2024 8:30 AM ET Company Participants Andrew Kramer - Vice President, Investor Relations Yossi Carmil - Chief Executive Officer Dana Gerner - Chief Financial Officer ...

CLBTW - Cellebrite Announces Fourth-Quarter 2023 Results

Record ARR of $315.7 million, up 27% year-over-year; Record Q4 revenue of $93.0 million, up 26% year-over-year primarily due to 26% growth in subscription revenue; Record Q4 adjusted EBITDA of $22.7 million, 24.4% adjusted EBITDA margin; Full-Year 2023 performance ...

CLBTW - Greenhaven Road Capital Main Fund Q4 2023 Investor Letter

2024-02-10 09:30:00 ET Summary Greenhaven Road is a boutique hedge fund with the patience and confidence to step outside of the norm. Greenhaven Road Capital digs deep, searching in places rarely trafficked to locate the few hidden gems that will outperform a diversified portfolio of ...

CLBTW - Cellebrite Revolutionizes Investigative Workflow with Groundbreaking End-to-End Platform to Solve More Cases Faster

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (Nasdaq: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced Case-to-Closure (C2C), an expanded end-to-end platform for examin...

Previous 10 Next 10